Market Tracker

10/23 12:30pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

107.25
Real-Time Quote
 +2.74 / +2.62%
Today’s Change
77.81
Today|||52-Week Range
109.56
+21.92%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.

Performance

1 month-2.12% 3 years+31.94%
3 months+4.41% 5 years+25.70%
1 year+34.59% Since inception+17.08%
Data through 10/23/2014

Quote Details

Previous close$104.51
Open day’s range105.82 – 107.41
Net asset value (NAV)104.44 (10/22/2014)
Daily volume31,657
Average volume (3 months)70,502
Data as of 12:26pm ET, 10/23/2014

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+25.70%+21.83%
Expense Gross exp ratio0.35%0.42%
Risk 5 year sharpe ratio1.611.39
Net assets$974.9M$1.5B
Average market cap$7.7B$27.2B
Average P/E31.729.1
Dividend / Share--0.20%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AUXL Auxilium Pharmaceuticals Inc4.32%
AVNR AVANIR Pharmaceuticals Class A3.89%
LCI Lannett Co Inc3.75%
SLXP Salix Pharmaceuticals Ltd3.54%
ENDP Endo International PLC3.45%
AGN Allergan Inc3.42%
MNK Mallinckrodt PLC3.40%
HZNP Horizon Pharma PLC3.38%
PRGO Perrigo Co PLC3.38%
ACT Actavis PLC3.35%